Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Chembiochem ; 13(7): 987-91, 2012 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-22505051

RESUMO

We demonstrate that the Ugi reaction enables chemoselective derivatization of biological amines, carboxylic acids, aldehydes, or ketones with a chromophore under one set of reaction conditions, even in the presence of water. Derivatization of neurotransmitters, hormones, disease biomarkers and other metabolites bodes well for systems biology and diagnostic medicine.


Assuntos
Aminoácidos/metabolismo , Biomarcadores/química , Cianetos/metabolismo , Metabolômica/métodos , Aminoácidos/química , Cianetos/química
2.
Bioorg Med Chem ; 19(24): 7679-89, 2011 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-22055717

RESUMO

Inhibitors of drug efflux pumps have great potential as pharmacological agents that restore the drug susceptibility of multidrug resistant bacterial pathogens. Most attention has been focused on the discovery of small molecules that inhibit the resistance nodulation division (RND) family drug efflux pumps in Gram-negative bacteria. The prototypical inhibitor of RND-family efflux pumps in Gram-negative bacteria is MC-207,110 (Phe-Arg-ß-naphthylamide), a C-capped dipeptide. Here, we report that C-capped dipeptides inhibit two chloramphenicol-specific efflux pumps in Streptomyces coelicolor, a Gram-positive bacterium that is a relative of the human pathogen Mycobacterium tuberculosis. Diversity-oriented synthesis of a library of structurally related C-capped dipeptides via an Ugi four component reaction and screening of the resulting compounds resulted in the discovery of a compound that is threefold more potent as a suppressor of chloramphenicol resistance in S. coelicolor than MC-207,110. Since chloramphenicol resistance in S. coelicolor is mediated by major facilitator superfamily drug efflux pumps, our findings provide the first evidence that C-capped dipeptides can inhibit drug efflux pumps outside of the RND superfamily.


Assuntos
Antibacterianos/farmacologia , Proteínas de Bactérias/metabolismo , Cloranfenicol/farmacologia , Dipeptídeos/química , Dipeptídeos/farmacologia , Proteínas de Membrana Transportadoras/metabolismo , Streptomyces coelicolor/efeitos dos fármacos , Farmacorresistência Bacteriana Múltipla/efeitos dos fármacos , Humanos , Streptomyces coelicolor/metabolismo , Relação Estrutura-Atividade
3.
J Org Chem ; 74(14): 5067-70, 2009 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-19476325

RESUMO

Passerini three-component reactions of aldehydes, isocyanides, and strong carboxylic acids (i.e., pK(a) < 2) yield alpha-acyloxycarboxamides and/or alpha-acylaminocarboxamides, the characteristic products of Ugi four-component reactions. We propose that alpha-acylaminocarboxamide formation with these substrates is a consequence of in situ Brønsted acid-catalyzed reaction of the isocyanide and aldehyde to yield an imine that participates in an Ugi-type reaction. The apparent transfer of the isocyanide alpha-carbon to protic solvents as a formyl group during imine formation is indicative of new isocyanide reactivity.

4.
J Org Chem ; 73(14): 5595-7, 2008 Jul 18.
Artigo em Inglês | MEDLINE | ID: mdl-18570401

RESUMO

Substoichiometric quantities of scandium and ytterbium triflate increase the yield of Ugi four component coupling reactions of aromatic aldehydes 2- to 7-fold. These rare earth metal triflates enhance the reaction yields primarily via activation of the imine intermediate of this multicomponent reaction.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...